BCL2 and central nervous system cancer: Also, PTX was capable of activating caspase-3 (the effector of apoptosis pathways) and reducing Bcl-2 expression (the anti-apoptotic protein) to repress glioma cell apoptosis [34], which was partially consistent with our findings.